echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > New Crown Virus: What should We Do If the drug doesn't work?

    New Crown Virus: What should We Do If the drug doesn't work?

    • Last Update: 2020-07-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    , June 24, 2020 /PRNewswire
    / -- There are no known treatments for COVID-19, and earlyclinical trials of the drug are disappointing
    results are disappointingU.SPresident Donald Trump called hydroxychloroquine a "game-changer." Recently, the World Health Organization suspended the trial of hydroxychloroquine for safety reasonsAlthough the antiviral drug Redsivir has been approved for emergency use in some countries, its effect simply is not significant, reducing the duration of the disease by about 30 per centA just-published clinical trial of plasmafor patients with severe or life-threatening COVID-19 has foundthat plasma does not help patients recover faster than standard therapiesof course, vaccines still offer some hopeTen vaccines are beingclinical trials, and more than 130 vaccines are being tested in preclinical trialsBut before we develop a safe vaccine that can provide long-lasting immunity, many obstacles remain to be overcomewe must be strong in case there is no safe and effective vaccine or treatmentWe may have to learn to co-exist with COVID-19 But what will this life look like? Photo Source: University of Glasgow Physical and Mental Health Deterioration
    Infections May Have Peaks and Lows, seasonal and localized outbreaks require a more subtle response than the current rigid blockade to date, 6.5 million cases of COVID-19 have been recorded worldwide This shows that the vast majority of people have not been exposed to the new coronavirus, and we are a long way from achieving mass immunity Group immunization requires 60 per cent of the world's 7.58 billion people to be immune, or 4.55 billion people At this point, scientists aren't even sure how long the immune system will last ongoing pandemics can exacerbate health inequalities within and between countries in a number of ways Developing countries may be less able to control the outbreak, and leaders will need to work together to curb the global spread of the virus coronavirus control measures can disrupt other public health interventions, such as childhood immunization, which can lead to outbreaks of other infectious diseases Concern has been expressed about the increase in cases of diphtheria, cholera, measles and polio, which is being eradicated noncommunicable diseases are also a cause for concern In some countries, the number of people who go to the hospital for emergencies such as heart attacks and strokes has declined Moreover, the diagnosis of diagnosis of cancer and treatment may continue to be delayed as doctors try to balance the risk of delayed treatment and COVID-19 infection during treatment Delays in access to and access to noncommunicable diseases can lead to long-term ill-health and premature death if the SARS outbreak is anything to go by, an outbreak of COVID-19 could lead to a surge in mental health disorders The authors of a four-year follow-up study of SARS survivors say the epidemic is a mental health and biological disaster with similar effects to other major disasters Survivors of the SARS outbreak experience high levels of mental illness and post-traumatic stress disorder, which are caused by a number of factors, including prolonged isolation from family and friends, extreme uncertainty during the disease and threat stocions to life social and economic impacts
    the social and broader economic costs of the epidemic may dwarf the cost of health Without vaccines, social distances will continue and different countries will adopt different control measures The impact of control measures on groups will be unfair, as it is more beneficial to young people and healthy people However, young people will face huge impacts, including from the looming world recession and the ensuing unemployment The close link between poverty and health suggests that it can harm long-term population health for those with jobs, they will no longer continue working as they did before COVID-19 Working from home is becoming entrenched, but mainly among the white-collar classes in rich countries Most blue-collar workers will have to return to work, use the relevant personal protective equipment, and take social isolation measures There is a known healthy socio-economic pattern where people with the worst health will be exposed to COVID-19 to the greatest extent possible photo source: Universitat Rovira i Virgili
    pandemic may also affect education The requirement of social distance may limit students' access to education through small shifts and staggered attendance The link between education and health is closely linked Any reduction in the quality or number of education seiscasts could have a significant impact on the lives of this generation of children and young people discussions among governments and the media about measures to control COVID-19 have focused on the trade-off between population and economic health and the relationship between the freedom of all groups and the need to protect the lives of minorities at greatest risk over time, without a vaccine or effective treatment, the discussion of these trade-offs is likely to continue But that balance may change The public and government may become increasingly reluctant to accept the economic harm that continues to limit the lives of most people We are likely to see a shift in focus - a shift in economic development, isolating at-risk groups, and allowing most people at lower risk of serious illness to continue living (BioValleyBioon.com) References: : : Coronavirus: what if the drugs don't work? 2 Fair Society Health Lives 3
    How do our money and resources tress rour health? 4
    Long-term-term-term-de-dimhs eos io-SARS survivors
    5: A War on Two Fronts: Cancer Care in the Time of THE COVID-19
    6
    Response to Covid-19 - A Once-in-a-Century? Draft Landscape of COVID-19 Candidate 8
    Effect of Convales cent Plasma Therapy on time to Clinical And Clinical in Patients With Ssevere and Life-bully covid-19 A Random Clinical Trial 9 Authorization for The CoVID-19 Treatment .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.